Impact of Regorafenib for HCC

Ghassan Abou-Alfa, MD of Memorial Sloan-Kettering discusses the impact of regorafenib for hepatocellular carcinoma (HCC) treatment. This was recorded at the 2017 Great Debates and Updates in GI Malign... Author: GiDebates2017 Added: 05/31/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts